I'm very realistic that the data might not be as good as hoped and I understand the risk associated. But you posting that the "word is getting out that Lympro isn't as effective as being touted" is utter bullshit to say the least.

No one outside the company and it's associates know about the effectiveness of LymPro and anyone who claims other wise is a liar. That, or, you think that people outside those two groups do know the results and the only way that is possible if insider trading is taking place. Which, I not only highly doubt, but if that was the case than I would be exiting this investment very swiftly, because again, I am very realistic about the risk and everything that could go wrong.

There is no soft pumping from me, only realistic observations.